ENGINEERING SHAPE OF POLYMERIC MICRO- AND NANOPARTICLES

• US 20080112886A1
• Filed: 09/07/2007
• Published: 05/15/2008
• Est. Priority Date: 09/08/2006
• Status: Abandoned Application

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: Katare, Yogesh K., Mitragotri, Samir, Champion, Julie A.
• Application Number:
  US11/851,974
• Publication Number:
  US 20080112886A1
• Time in Patent Office: Days
• US Class Current: 424/9.1
• CPC Class Codes: A61K 9/0097 Micromachined devices; Microelectromechanical systems [MEMS]; Devices obtained by lithographic treatment of silicon; Devices comprising chips intradermal microneedle arrays A61K9/0021; MEMS in general B81B7/02
• CPC Class Codes: A61K 9/1694 resulting in granules or microspheres of the matrix type containing more than 5% of excipient
• CPC Class Codes: A61K 9/5192 Processes

Abstract

Compositions containing polymeric micro- and nanoparticles with non-spherical shapes and methods for making and using such particles are described herein. The particles have a size range from an average diameter of about Compositions containing polymeric micro- and nanoparticles with non-spherical shapes and methods for making and using such particles are described herein. The particles have one or more dimensions ranging from about 5 nm to about 100 μm, preferably about 100 nm to 10 μm. The particles can have any of a wide variety of non-spherical shapes. The particles are generally formed by manipulation of spherical particles embedded in a polymeric film. A wide variety of resulting shapes can be made. The resulting shape is a function of whether the films are manipulated in a first and/or second dimension, and the processes used to liquefy the microparticles. Variations of the method of manufacture may be used to generate particles having the desired shapes in large, reproducible quantities. The resulting non-spherical shaped particles can be used to alter uptake by phagocytic cells and thereby clearance by the reticuloendothelial system.

Claims

1. A method of making non-spherical particles comprising

providing polymeric nano or micro particles in a polymeric film and applying physical manipulation of the polymeric film to change the shape of the particles.

2. The method of claim 1, further comprising

liquefying the nano or micro particles in the polymeric film and resolidifying the particles after manipulation of the film.

3. The method of claim 2 wherein the particles are liquefied by adding a solvent in which the polymeric film is immiscible or by applying heat.

4. The method of claim 1 wherein the film is manipulated in a first direction.

5. The method of claim 4 wherein the film is manipulated in a second direction.

6. The method of claim 1 wherein the particles adhere to the polymer film via ionic bonds or hydrogen binding.

7. The method of claim 1 wherein the polymeric film comprises a plasticizer.

8. A polymeric film comprising non-spherical nano or micro particles, wherein the polymeric film comprises a different polymer than the nano or micro particles.

9. The film of claim 8, wherein the film is prepared by a method comprising

providing spherical nano or micro particles in a polymeric film and applying physical manipulation of the polymeric film to change the shape of the particles.

10. Non-spherical nano or micro particles prepared by a method comprising

providing spherical nano or micro particles in a polymeric film and applying physical manipulation of the polymeric film to change the shape of the particles.

11. The particles of claim 10 further comprising a prophylactic, therapeutic or diagnostic agent.

12. The particles of claim 10 further comprising a targeting agent.

13. A method of treating an organism by administering at least one therapeutic agent encapsulated in at least one non-spherical nano or micro particle.

14. The method of claim 13 where the therapeutic agent and particle material are the same.

15. The method of claim 13 where the particles are administered orally, intravenously, nasally, pulmonarily, rectally or topically.

16. A method of diagnosing an organism by administering at least one diagnostic agent encapsulated in at least one non-spherical nano or microparticle.